Ameritas Investment Partners, Inc. Acrivon Therapeutics, Inc. Transaction History
Ameritas Investment Partners, Inc.
- $2.98 Billion
- Q3 2024
A detailed history of Ameritas Investment Partners, Inc. transactions in Acrivon Therapeutics, Inc. stock. As of the latest transaction made, Ameritas Investment Partners, Inc. holds 695 shares of ACRV stock, worth $0. This represents 0.0% of its overall portfolio holdings.
Number of Shares
695
Previous 695
-0.0%
Holding current value
$0
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding ACRV
# of Institutions
53Shares Held
23.2MCall Options Held
0Put Options Held
0-
Ra Capital Management, L.P. Boston, MA8.34MShares$00.0% of portfolio
-
Perceptive Advisors LLC New York, NY5.36MShares$00.0% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il2.14MShares$00.0% of portfolio
-
Sands Capital Ventures, LLC Arlington, VA2.12MShares$00.0% of portfolio
-
Wellington Management Group LLP Boston, MA888KShares$00.0% of portfolio